James Lazarovits is the CEO and Co-Founder of Archon Biosciences, a leader at the intersection of materials engineering and artificial intelligence. James brings over 15 years of experience building, mentoring, and investing in deep tech startups across AI, software, hardware, and robotics. Before founding Archon, James was at the forefront of AI-driven computational protein design as a post-doctoral fellow and later research faculty at the Institute for Protein Design at the University of Washington, under the direction of 2024 Nobel Laureate, David Baker. There, he contributed to pioneering methods that integrate machine learning and molecular engineering to create next-gen therapeutic proteins. Jamie earned his PhD in nanotechnology engineering from the University of Toronto where he worked under Nanomedicine expert, Dr. Warren Chan. His doctoral work focused on overcoming biological delivery barriers, using nano materials and deep learning, laying the groundwork for his later contributions to rational protein design.